Strides Pharma Science Ltd

NSE: STAR · BSE: 532531 · Pharmaceuticals & Biotechnology · 28 announcements

Share price: ₹1,103.30
Market cap: ₹10,169 Cr
Revenue (annual): ₹4,859 Cr
Net profit (annual): ₹556.2 Cr
P/E (TTM): 16.6×Sector 47.4×
Promoter holding: 27.91%+0.00% QoQ
FII holding: 28.40%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Merger & Restructuring 4 Financial Results 4 Earnings Call 4 Business Update 4 Results Update 2 Other Announcement 2 Dividend 2 Board Meeting Date 2 Annual General Meeting 2 Management Change 1 Board Meeting Outcome 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

31 Jul 2026 12:39 IST NSE

Results Update

Strides Pharma Science Results Update

Strides Pharma Science reported a 13% YoY revenue growth to ₹1,265.4 Crore for Q1FY27. EBITDA grew 5.4% to ₹229.8 Crore despite geopolitical cost disruptions.

Value: ₹1,265 Cr

Read the filing ↗

18 May 2026 14:27 IST BSE

Results Update

Strides Pharma Science Results Update

Strides reported strong FY26 performance with EBITDA reaching ₹9,253 million. The Board recommended a dividend of ₹5 per share, reflecting robust growth in Ex-US markets.

Read the filing ↗